DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Cappellini MD, Cohen A, Piga A. et al.
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.
Blood 2006; 107: 3455-3462
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.